Latest Schedule 13G passive stakes

Federated Hermes, Inc. and associated entities report a 4.45% beneficial ownership stake in SCYNEXIS Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 4.15% of Ovid Therapeutics Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 4.15% of Ovid Therapeutics Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 17.17% of Minerva Neurosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 17.17% of Minerva Neurosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a beneficial ownership stake of 4.59% in MGP Ingredients, Inc. as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a beneficial ownership stake of 4.59% in MGP Ingredients, Inc. as of June 30, 2026.

Federated Hermes, Inc. and related entities have reported beneficial ownership of 5.68% of LifeMD, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have reported beneficial ownership of 5.68% of LifeMD, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 10.31% of Forte Biosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 10.31% of Forte Biosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities have filed an amended Schedule 13G, reporting beneficial ownership of 8,509,678 shares, representing 8.68% of aTyr Pharma Inc.'s common stock.

Federated Hermes, Inc. and associated entities have filed an amended Schedule 13G, reporting beneficial ownership of 8,509,678 shares, representing 8.68% of aTyr Pharma Inc.'s common stock.

Mitchell and Sharon Rosen, along with their associated trusts, have disclosed a combined beneficial ownership of 7,200,000 shares, representing 8.9% of Bed Bath & Beyond's common stock.

Davidson Kempner Capital Management LP and affiliated entities have reported beneficial ownership of over 5% of PowerBank Corporation's common shares.

Several entities associated with Millennium Management have reported a combined beneficial ownership of over 5% in Protara Therapeutics, Inc.

Host-Plus Pty Ltd, as trustee for the HOSTPLUS Pooled Superannuation Trust, has increased its beneficial ownership in EBR Systems, Inc. to 10.6% following a retail entitlement offer.

Wasatch Advisors LP has reported beneficial ownership of 5.0% of Champion Homes Inc. common stock as of June 30, 2026.

Harraden Circle Investments and affiliated entities have reported beneficial ownership of 2,000,000 shares, representing 6.96% of Graf Global Corp.'s Class A common stock.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.3% of Ares Acquisition Corporation III's Class A Ordinary Shares as of June 30, 2026.

Neuberger Berman Group LLC and its affiliate Neuberger Berman Investment Advisers LLC have filed a Schedule 13G, reporting beneficial ownership of 3.2% of Arcosa Inc. common stock as of June 30, 2026.

Neuberger Berman Group LLC and its affiliates have reported beneficial ownership of 7.6% of Neogen Corp's common stock as of June 30, 2026.

Neuberger Berman Group LLC and its affiliates have reported a beneficial ownership stake of 6.9% in UFP Technologies Inc., as of June 30, 2026.

First Light Asset Management, LLC and Mathew P. Arens have jointly filed a Schedule 13G, reporting beneficial ownership of 10.74% of TriSalus Life Sciences, Inc. common stock as of June 30, 2026.

Long Path Smaller Companies Fund, LP and affiliated entities report a beneficial ownership of 8.6% in Mesa Laboratories, Inc. following an amendment to their Schedule 13G filing.

Neuberger Berman Group LLC and its affiliates report beneficial ownership of 5.1% of Accuray Inc. common stock as of June 30, 2026.

Karpus Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 1,893,627 shares, representing 21.63% of Tavia Acquisition Corp.'s common stock as of June 30, 2026.

Karpus Management, Inc. has filed a Schedule 13G, reporting 0.00% beneficial ownership of Rising Dragon Acquisition Corp. common stock as of June 30, 2026.

Karpus Management, Inc. has filed a Schedule 13G, revealing beneficial ownership of 1,286,528 shares, representing 14.92% of the outstanding common stock of Origin Investment Corp I.

Karpus Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 961,303 shares, representing 10.07% of the outstanding common stock of Melar Acquisition Corp. I.